The luciferase assay market is poised to embark on an impressive growth trajectory, with a promising CAGR of 7.00%. Distinguished industry experts have forecasted that by the year 2034, the market is anticipated to soar to an astounding valuation of USD 3,022.90 million, depicting a substantial upsurge from its present value of USD 1,536.70 million
| Attributes | Details |
|---|---|
| Luciferase Assay Market Size, 2024 | USD 1,536.70 million |
| Market Size, 2034 | USD 3,022.90 million |
| Value CAGR (2024 to 2034) | 7.00% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Drivers |
|
|---|---|
| Challenges |
|
| Attributes | Details |
|---|---|
| Product Type | Luciferase Assays |
| Market share in 2024 | 35.00% |
Luciferase assays are gaining popularity among researchers due to their compatibility with a wide range of products such as reagents, kits, and instruments. Moreover, the upsurge in drug discovery and development has led to the increasing adoption of these assays in recent years.
Furthermore, the increasing availability of advanced technologies, such as high-throughput screening systems and automated instrumentation, has made it easier to perform these assays on a large scale.
| Attributes | Details |
|---|---|
| Application | Protein-protein Interaction |
| Market Share in 2024 | 27.60% |
Rising need for understanding complex cellular processes and developing effective drugs to treat specific diseases has led researchers to use protein-protein interactions as a common method. Increasing focus on personalized medicine is driving the growth of the protein-protein interaction segment.
Personalized medicine involves developing drugs tailored to the genetic makeup of individual patients. To do this, researchers need to study the interactions between specific proteins involved in disease pathways.
Principal Consultant
| Countries | CAGR from 2024 to 2034 |
|---|---|
| United States | 3.20% |
| China | 6.00% |
| Germany | 2.50% |
| India | 7.60% |
| Australia | 5.30% |
The CAGR of the market in the United States during the forecast period is anticipated to be 3.20%. The United States dominates the market in North America due to strong government financing for research into innovative test methodologies. Although demand for luciferase assays in this country has remained robust, operations targeting the market have recently shifted.
The market is expected to register a CAGR of 6.00% in China through 2034. The government plays a major role in the growth of the luciferase assay market in China by providing funding and facilities for drug discoveries and development.
China has greater development potential in this industry. Many firms are focusing their resources on economically growing regions, especially in the Asia Pacific, to explore product potential that is expected to increase luciferase assay sales.
The market is expected to progress at a CAGR of 2.50% in Germany throughout the forecast period. The need for advanced technology is anticipated to drive the luciferase assay market in Germany.
By providing high sensitivity, low background, and real-time detection capabilities, these assays are gaining more market potential than traditional methods in the country. Moreover, the high usage of luciferase assays in laboratories across Germany, especially for pharmaceutical purposes, has been observed in recent years.
The market is expected to progress at a CAGR of 5.30% in Australia throughout the forecast period. Escalating demand for biotechnology and life science research is driving up the demand for the luciferase assay market in the region. Moreover, the expanding pharmaceutical industry is anticipated to gain a major market share in Australia in the coming years.
The market is expected to progress at a CAGR of 7.60% in India. Advancements in technology have led to the development of new and improved luciferase assay kits, making them more accessible and affordable to researchers and scientists in India.
Moreover, the luciferase assay market in India is expected to grow due to the increasing demand for personalized medicine in the region. As personalized medicine becomes more prevalent, there will be a need for more precise and efficient tools to diagnose and treat diseases.
The luciferase assay market is highly competitive, with numerous players involved in the development and production of assay kits and reagents. Companies are constantly innovating and launching new products to stay ahead of the competition.
Additionally, partnerships, collaborations, and mergers and acquisitions are common strategies these players adopt to expand their market presence and enhance their product portfolio.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a leading biotechnology company that offers a wide range of products and services to the life science, healthcare, and industrial markets. The company has a global presence and operates through four business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
One of the key products offered by Thermo Fisher Scientific Inc. is its range of Luciferase Assays. These assays are designed to measure the activity of luciferase enzymes, which are commonly used as reporter genes in molecular biology research.
The assay kits offered by Thermo Fisher Scientific Inc. are used to measure the expression of genes, monitor protein-protein interactions, and detect changes in cellular signaling pathways.
PerkinElmer Inc.
PerkinElmer Inc. is a global leader in providing innovative products, services, and solutions to the life sciences, diagnostics, and applied markets. The company's diverse portfolio includes a wide range of products, including analytical instruments, reagents, software, and consumables.
PerkinElmer's luciferase assays are among its most popular products, offering researchers a range of options for measuring gene expression and monitoring cellular signaling pathways.
PerkinElmer's assays are designed to be highly sensitive, reliable, and easy to use. The company offers a range of assay formats, including reporter gene assays, dual-luciferase reporter assays, and firefly assay kits.
Acquisition, Mergers, and Recent Development
| Attribute | Details |
|---|---|
| Estimated Market Size (2024) | USD 1,536.70 million |
| Projected Market Size (2034) | USD 3,022.90 million |
| Anticipated Growth Rate (2024 to 2034) | 7.00% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | USD million or billion for Value and Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; Middle East & Africa (MEA); East Asia; South Asia and Oceania |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa |
| Key Segments Covered | Product Type and Application |
| Key Companies Profiled | Promega Corporation; PerkinElmer Inc.; Thermo Fisher Scientific Inc.; Abcam plc; Geno Technology Inc.; BioTek Instruments, Inc.; Becton, Dickinson and Company; Merck KGaA; Cell Signaling Technology, Inc.; Danaher Corporation. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The CAGR of the market in the United States from 2024 to 2034 is estimated to be 3.20%.
The market is expected to grow at a CAGR of 7.00%.
The market size is expected to be worth USD 1,536.70 million in 2024.
The CAGR of the market in China from 2024 to 2034 is estimated to be 6.00%.
The market is estimated to get as big as USD 3,022.90 million by 2034.
The market can be divided into the following segments: product type, application, and region.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Assay Type 5.1. Beta-Galactosidase Assays 5.2. Fluorescent Protein Related Assays 5.3. Chloramphenicol Acetyltransferase Assays 5.4. Others 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 6.1. Gene Expression 6.2. Post-Translational Modification 6.3. Protein-Protein Interaction 6.4. Metabolic Activity 6.5. Others 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 7.1. North America 7.2. Latin America 7.3. Western Europe 7.4. Eastern Europe 7.5. South Asia and Pacific 7.6. East Asia 7.7. Middle East and Africa 8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Life Technologies 17.2. Sigma Aldrich 17.3. Thermo Fisher 17.4. Promega 17.5. Roche Applied Sciences 17.6. Switchgear Genomics 17.7. OriGene 17.8. EMD Millipore 17.9. Clontech 17.10. Gold Biotechnology 17.11. Lonza 17.12. GE Healthcare Life Sciences 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Luciferase Assay Market
